180 related articles for article (PubMed ID: 10408808)
1. Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier.
Poduslo JF; Curran GL; Sanyal B; Selkoe DJ
Neurobiol Dis; 1999 Jun; 6(3):190-9. PubMed ID: 10408808
[TBL] [Abstract][Full Text] [Related]
2. Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier.
Poduslo JF; Curran GL; Haggard JJ; Biere AL; Selkoe DJ
Neurobiol Dis; 1997; 4(1):27-34. PubMed ID: 9258909
[TBL] [Abstract][Full Text] [Related]
3. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
[TBL] [Abstract][Full Text] [Related]
4. Beta-sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood-brain barrier permeability and resistance to proteolytic degradation in plasma.
Poduslo JF; Curran GL; Kumar A; Frangione B; Soto C
J Neurobiol; 1999 Jun; 39(3):371-82. PubMed ID: 10363910
[TBL] [Abstract][Full Text] [Related]
5. Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice.
LaRue B; Hogg E; Sagare A; Jovanovic S; Maness L; Maurer C; Deane R; Zlokovic BV
J Neurosci Methods; 2004 Sep; 138(1-2):233-42. PubMed ID: 15325132
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation.
Kandimalla KK; Curran GL; Holasek SS; Gilles EJ; Wengenack TM; Poduslo JF
J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932
[TBL] [Abstract][Full Text] [Related]
7. Blood-brain barrier transport of circulating Alzheimer's amyloid beta.
Zlokovic BV; Ghiso J; Mackic JB; McComb JG; Weiss MH; Frangione B
Biochem Biophys Res Commun; 1993 Dec; 197(3):1034-40. PubMed ID: 8280117
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier.
Ito S; Ohtsuki S; Terasaki T
Neurosci Res; 2006 Nov; 56(3):246-52. PubMed ID: 16926058
[TBL] [Abstract][Full Text] [Related]
9. Lack of brain-to-blood efflux transport activity of low-density lipoprotein receptor-related protein-1 (LRP-1) for amyloid-beta peptide(1-40) in mouse: involvement of an LRP-1-independent pathway.
Ito S; Ueno T; Ohtsuki S; Terasaki T
J Neurochem; 2010 Jun; 113(5):1356-63. PubMed ID: 20367755
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system.
Wu D; Boado RJ; Pardridge WM
J Pharmacol Exp Ther; 1996 Jan; 276(1):206-11. PubMed ID: 8558431
[TBL] [Abstract][Full Text] [Related]
11. Drug targeting to the brain using avidin-biotin technology in the mouse; (blood-brain barrier, monoclonal antibody, transferrin receptor, Alzheimer's disease).
Jeong Lee H; Pardridge WM
J Drug Target; 2000; 8(6):413-24. PubMed ID: 11328667
[TBL] [Abstract][Full Text] [Related]
12. Plasma pharmacokinetics, nervous system biodistribution and biostability, and spinal cord permeability at the blood-brain barrier of putrescine-modified catalase in the adult rat.
Reinholz MM; Haggard JJ; Curran GL; Poduslo JF
Exp Neurol; 1999 Sep; 159(1):191-203. PubMed ID: 10486187
[TBL] [Abstract][Full Text] [Related]
13. Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat.
Bickel U; Schumacher OP; Kang YS; Voigt K
J Pharmacol Exp Ther; 1996 Jul; 278(1):107-13. PubMed ID: 8764341
[TBL] [Abstract][Full Text] [Related]
14. Enhanced permeabilities of cationized-bovine serum albumins at the blood-nerve and blood-brain barriers in awake rats.
Wadhwani KC; Shimon-Hophy M; Rapoport SI
J Neurosci Res; 1992 Jul; 32(3):407-14. PubMed ID: 1433388
[TBL] [Abstract][Full Text] [Related]
15. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta.
Zlokovic BV; Martel CL; Mackic JB; Matsubara E; Wisniewski T; McComb JG; Frangione B; Ghiso J
Biochem Biophys Res Commun; 1994 Dec; 205(2):1431-7. PubMed ID: 7802679
[TBL] [Abstract][Full Text] [Related]
16. Brain iron homeostasis.
Moos T
Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
[TBL] [Abstract][Full Text] [Related]
17. Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat.
Isakovic AJ; Abbott NJ; Redzic ZB
J Neurochem; 2004 Jul; 90(2):272-86. PubMed ID: 15228584
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro evidence for nonrestricted transport of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein tetraacetoxymethyl ester at the blood-brain barrier.
Hirohashi T; Terasaki T; Shigetoshi M; Sugiyama Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):813-9. PubMed ID: 9023295
[TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease.
Matsumoto Y; Yanase D; Noguchi-Shinohara M; Ono K; Yoshita M; Yamada M
Dement Geriatr Cogn Disord; 2007; 23(4):241-5. PubMed ID: 17310121
[TBL] [Abstract][Full Text] [Related]
20. Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding.
Liu X; Smith BJ; Chen C; Callegari E; Becker SL; Chen X; Cianfrogna J; Doran AC; Doran SD; Gibbs JP; Hosea N; Liu J; Nelson FR; Szewc MA; Van Deusen J
J Pharmacol Exp Ther; 2005 Jun; 313(3):1254-62. PubMed ID: 15743928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
